Overview / Abstract: |
Are you aware of the latest evidence-based strategies in ulcerative colitis (UC)? Looking to expand your ability to incorporate patient-centric factors into selection of therapy for UC? Navigate through this novel, interactive self-directed activity designed to optimize your decision making in selection of therapy for UC. View expert perspectives and insights who can help you apply newer strategies such as treat-to-target (T2T) and therapeutic drug monitoring (TDM) for the treatment for your UC patients. Also included are downloadable decision aids to share with your patients and “how I do it” patient and clinician interactions to help guide conversations on goal setting and treatment selection. Don’t get left behind on the latest UC therapies and treatment strategies. |
Expiration |
Jul 21, 2024 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Online |
Credits / Hours |
1.0 |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Millie Long, MD, MPH Neilanjan Nandi, MD |
Sponsors / Supporters / Grant Providers |
Provided by the Academy for Continued Healthcare Learning (ACHL). Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. |
Keywords / Search Terms |
ACHL CME, CE, Takeda, Neilanjan Nandi, Ulcerative Colitis, UC, Crohn’s Disease, Crohn’s, CD, IBD, QOL, treatment, goals, T2T, treat-to-target, diagnosis, Disease Monitoring, corticosteroid dependence, inflammatory bowel disease, quality of life, inflammatory bowel disease, vedolizumab, DMARD, biologic Free CE CME |